| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of PRMT5 mRNA | CTD | PMID:21570461 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:1309053 | 6480464 | 2,4-dinitrotoluene affects the expression of PRMT5 mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:1309053 | 6480464 | 2,6-dinitrotoluene affects the expression of PRMT5 mRNA | CTD | PMID:21346803 |
| 2-methylcholine | affects expression | ISO | RGD:1319178 | 6480464 | beta-methylcholine affects the expression of PRMT5 mRNA | CTD | PMID:21179406 |
| 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PRMT5 mRNA | CTD | PMID:20188158 |
| 4,4'-diaminodiphenylmethane | increases expression | EXP | | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of PRMT5 mRNA | CTD | PMID:18648102 |
| Aroclor 1254 | increases expression | ISO | RGD:1319178 | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of PRMT5 mRNA | CTD | PMID:16934159 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PRMT5 gene | CTD | PMID:20938992 |
| clofibric acid | multiple interactions | ISO | RGD:1309053 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PRMT5 mRNA | CTD | PMID:17602206 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1319178 | 6480464 | Copper Sulfate results in decreased expression of PRMT5 mRNA | CTD | PMID:19549813 |
| coumestrol | increases expression | ISO | RGD:1319178 | 6480464 | Coumestrol results in increased expression of PRMT5 mRNA | CTD | PMID:19167446 |
| cyclosporin A | increases expression | ISO | RGD:1319178 | 6480464 | Cyclosporine results in increased expression of PRMT5 mRNA | CTD | PMID:20106945 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of PRMT5 mRNA | CTD | PMID:17361019 |
| elemental selenium | increases expression | ISO | RGD:1319178 | 6480464 | Selenium results in increased expression of PRMT5 mRNA | CTD | PMID:19244175 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PRMT5 gene | CTD | PMID:20938992 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PRMT5 gene | CTD | PMID:20938992 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:1309053 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PRMT5 mRNA | CTD | PMID:17602206 |
| paracetamol | decreases expression | ISO | RGD:1319178 | 6480464 | Acetaminophen results in decreased expression of PRMT5 mRNA | CTD | PMID:21420995 |
| quercetin | decreases expression | ISO | RGD:1319178 | 6480464 | Quercetin results in decreased expression of PRMT5 mRNA | CTD | PMID:21632981 |
| selenium atom | increases expression | ISO | RGD:1319178 | 6480464 | Selenium results in increased expression of PRMT5 mRNA | CTD | PMID:19244175 |
| trimellitic anhydride | increases expression | EXP | | 6480464 | trimellitic anhydride results in increased expression of PRMT5 mRNA | CTD | PMID:19042947 |
| valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of PRMT5 mRNA | CTD | PMID:17292431 |